NLRP6 as a candidate segmental barrier to carcinogenesis in the human gut: a hypothesis
It is proposed that NLRP6 may function as one candidate component of a segment-restricted epithelial defence and mucosal immune surveillance network in the human gut, potentially shaping CRC-relevant inflammatory and barrier conditions rather than acting as an established human tumour-suppressive mechanism.